The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
End of life (EOL) care in patients with metastatic lung cancer harboring EGFR-mutations.
 
Jessica Ruth Bauman
No Relationships to Disclose
 
Zofia Piotrowska
No Relationships to Disclose
 
Emily Scribner
No Relationships to Disclose
 
Brandon Temel
No Relationships to Disclose
 
Lecia V. Sequist
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; GlaxoSmithKline; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim; Momenta Pharmaceuticals
Research Funding - Celgene; Debiopharm Group; Genentech; GlaxoSmithKline; Mirati Therapeutics; Peregrine Pharmaceuticals; Sanofi
 
Jennifer S. Temel
Research Funding - Helsinn Therapeutics (Inst)
Travel, Accommodations, Expenses - Helsinn Therapeutics